Journey Medical Corporation
DERM
$6.33
$0.081.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.62M | 14.63M | 14.86M | 13.03M | 15.26M |
| Total Other Revenue | 1.00M | -- | -- | -- | 0.00 |
| Total Revenue | 13.62M | 14.63M | 14.86M | 13.03M | 15.26M |
| Cost of Revenue | 2.24M | 5.29M | 6.54M | 6.82M | 2.25M |
| Gross Profit | 11.38M | 9.34M | 8.31M | 6.21M | 13.01M |
| SG&A Expenses | 10.06M | 11.40M | 10.33M | 8.42M | 9.84M |
| Depreciation & Amortization | 3.42M | -- | -- | -- | 3.77M |
| Other Operating Expenses | -4.55M | -- | -- | -- | -- |
| Total Operating Expenses | 11.39M | 17.52M | 17.78M | 23.12M | 17.36M |
| Operating Income | 2.23M | -2.89M | -2.93M | -10.09M | -2.10M |
| Income Before Tax | 1.58M | -2.39M | -3.36M | -10.44M | -2.02M |
| Income Tax Expenses | 61.00K | -- | -- | -- | 126.00K |
| Earnings from Continuing Operations | 1.52M | -2.39M | -3.36M | -10.44M | -2.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.52M | -2.39M | -3.36M | -10.44M | -2.14M |
| EBIT | 2.23M | -2.89M | -2.93M | -10.09M | -2.10M |
| EBITDA | 3.22M | -2.08M | -2.11M | -9.28M | -1.29M |
| EPS Basic | 0.07 | -0.12 | -0.17 | -0.53 | -0.11 |
| Normalized Basic EPS | 0.05 | -0.11 | -0.11 | -0.33 | -0.07 |
| EPS Diluted | 0.07 | -0.12 | -0.17 | -0.53 | -0.12 |
| Normalized Diluted EPS | 0.05 | -0.11 | -0.11 | -0.33 | -0.07 |
| Average Basic Shares Outstanding | 21.31M | 20.54M | 19.99M | 19.76M | 18.69M |
| Average Diluted Shares Outstanding | 21.31M | 20.54M | 19.99M | 19.76M | 18.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |